Medical Communications

Showing 15 posts of 6402 posts found.

molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …
shutterstock_95714119

Meta-analysis reinforces efficacy of commercially available steroids in hospitalised COVID-19 patients

September 4, 2020 Medical Communications, Research and Development COVID-19, pharma, steroids

A new meta-analysis of seven studies worldwide investigating the benefit for commercially available steroid therapies in the treatment of COVID-19 …
images_1

Operation Warp Speed’s top doctor says coronavirus vaccine likely won’t be approved until after November

September 4, 2020 Medical Communications

Dr Moncef Slaoui, the leading doctor involved with Operation Warp Speed, has said it is unlikely a vaccine for the …
782px-golden_hamster_front_1

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters

September 4, 2020 Medical Communications COVID-19, J&J, JJ

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 4, 2020 Medical Communications

The top 10 news stories this week largely cover coronavirus, as Sanofi is halting clinical trials treating serious COVID-19 patients …
tiktok-5323005_960_720

J&J issues warning after teen dies from Benadryl TikTok challenge

September 3, 2020 Medical Communications

One teen has died after taking large amounts of the antihistamine Benadryl as part of a social media “challenge” on …
3dmammogram

University of Illinois at Chicago’s new breast cancer drug is safe and can halt disease progression, according to a Phase 1 trial

August 28, 2020 Medical Communications Cancer, Cancers, breast cancer

A new breast cancer drug, called TTC-352, can halt the spread of the disease and is safe according to a …
49720569077_fac396d536_b

US signs deal to buy 150 million rapid COVID-19 tests from Abbott

August 28, 2020 Medical Communications

The US government has signed a deal to buy Abbott’s rapid coronavirus test after the FDA gave it Emergency Use …
800px-lsd_tabs

First clinical trial for MDMA and LSD combination set to go ahead

August 28, 2020 Medical Communications LSD, MDMA, PTSD

Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy. The Phase 1 …
200707-f-zc102-1004

Korea approves Celltrion’s Phase 1 trial of COVID-19 antiviral antibody treatment

August 28, 2020 Medical Communications COVID-19, antibodies, coronavirus vaccine

Celltrion Group has announced that the Korean Ministry of Food and Drug Safety has approved the company’s Investigational New Drug …
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

August 28, 2020 Medical Communications COVID-19, Vaccine, coronavirus vaccine, top 10

The top 10 news stories this week are focused on coronavirus vaccines and treatments, as China is set to move …
hamburger-cheeseburger-burger-bun

Obesity increases risk of death from coronavirus and could make vaccines less effective

August 27, 2020 Medical Communications obesity

Obesity can increase the risk of death from coronavirus by nearly 50% and could make a vaccine less effective, according …
fifififif

Working Life Interview: Fiona Huzarski, Vice President of Global HR, ADVANZ PHARMA

August 26, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Working Life, feature

“Every company is different, so you have to be open-minded and receptive to the culture when joining.” Can you briefly …
800px-unternehmenssitz_janssen-cilag

Janssen granted US approval for multiple myeloma drug combination

August 21, 2020 Medical Communications

The FDA has approved Genmab and Janssen’s Darzalex (daratumumab) as a treatment for relapsed and refractory multiple myeloma, when combined …
The Gateway to Local Adoption Series

Latest content